Status:
COMPLETED
Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage
Lead Sponsor:
Rune Rasmussen
Conditions:
Subarachnoid Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether prostacyclin is effective in prevention of cerebral vasospasm in patients with subarachnoidal hemorrhage (SAH).
Eligibility Criteria
Inclusion
- SAH verified by CT
- Aneurysm identified and treated
- Fisher grade 3 + 4
- WFNS grade 1-4 (World Federation of Neurosurgical Societies )
Exclusion
- Pregnancy/lactation
- Heard failure
- Kidney failure
- Liver failure
- Hemorrhagic diathesis
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01447095
Start Date
October 1 2011
End Date
June 1 2014
Last Update
July 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, dep. of neurosurgery
Copenhagen, Denmark, 2200